Skip to main content
Independent and nonpartisan. SaveYourState is a civic information resource. It is not a government website and is not affiliated with any government agency, party, or campaign.

New York · 2025 Regular Session · Bill

A 4296: Limits the off label use of antipsychotic drugs on elderly patients with dementia

In committee Official data

  1. Introduced
  2. In committee
  3. Passed one chamber
  4. Passed both chambers
  5. Enacted

Last official action: ·Record last updated:

Plain-language summary

A 4296 is a bill introduced in the New York House on February 4, 2025. According to its official title, it concerns: Limits the off label use of antipsychotic drugs on elderly patients with dementia. Primary sponsor: Alicia Hyndman (Democratic). Most recent recorded action (January 7, 2026): REFERRED TO HEALTH.

Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written

Official summary

Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.

Limits the off label use of antipsychotic drugs with black box warnings on elderly patients with dementia; provides for professional misconduct for any health care professional who uses such drug on such patient.

Sponsors

Sponsors by party (alphabetical): Democratic 1

NameRolePartyChamberDistrict
Alicia HyndmanPrimary sponsorDemocraticHouse29

“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.

Recent official actions

  1. REFERRED TO HEALTH
  2. REFERRED TO HEALTH

Sources

  1. Open States / Plural (data from the official legislature website)
  2. Official legislature source